| Bioactivity | JAK-IN-34 (compound 11n) is a potent against of JAKs with IC50 values of 0.40, 0.83, 2.10, 1.95 nM target JAK1, JAK2, JAK3, TYK2, respectively. JAK-IN-34 reduces joint swelling with good safety[1]. |
| Name | JAK-IN-34 |
| CAS | 2068766-90-3 |
| Formula | C27H26N6O |
| Molar Mass | 450.53 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jinbao Xiang, et al. Design, synthesis, and pharmacological evaluation of quinazoline derivatives as novel and potent pan-JAK inhibitors. Bioorg Chem. 2023. |
JAK-IN-34
CAS: 2068766-90-3 F: C27H26N6O W: 450.53
JAK-IN-34 (compound 11n) is a potent against of JAKs with IC50 values of 0.40, 0.83, 2.10, 1.95 nM target JAK1, JAK2, JA
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.